Clinicopathological features of and risk factors for multiple primary melanomas

JAMA

Volumn 294, Issue 13, 2005, Pages 1647-1654

  Ferrone, Cristina R ^a   Porat, Leah Ben ^a   Panageas, Katherine S ^a   Berwick, Marianne ^a   Halpern, Allan C ^a   Patel, Ami ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER RISK; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FAMILY HISTORY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR;

EID: 26044481446     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.13.1647     Document Type: Review

References (21)

1. Neugut AI, Meadows AT, Robinson E. Multiple Primary Cancers. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:445-469.
2. American Cancer Society. Facts and Figures 2005. Atlanta, Ga: American Cancer Society. In press.
3. DiFronzo LA, Wanek LA, Elashoff R, Morton DL. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol. 1999;6:705-711.
4. Blackwood MA, Holmes R, Synnestvedt M, et al. Multiple primary melanoma revisited. Cancer. 2002;94:2248-2255.
5. Pack GT, Scharnagel IM, Hillyer RA. Multiple primary melanoma: a report of sixteen cases. Cancer. 1952;5:1110.
6. Slingluff CL Jr, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993;113:330-339.
7. Brobeil A, Rapaport D, Wells K, et al. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997;4:19-23.
8. Kang S, Barnhill RL, Mihm MC Jr, Sober AJ. Multiple primary cutaneous melanomas. Cancer. 1992;70:1911-1916.
9. Cascinelli N, Fontana V, Cataldo I, Balzarini GP. Multiple primary melanoma. Tumori. 1975;61:481-486.
10. Johnson TM, Hamilton T, Lowe L. Multiple primary melanomas. J Am Acad Dermatol. 1998;39:422-427.
11. Giles G, Staples M, McCredie M, Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433-438.
12. Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer. 2003;97:639-643.
13. Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM. Dysplastic nevi in association with multiple primary melanoma. Cancer Res. 1988;48:1016-1018.
14. Tucker MA, Fraser MC, Goldstein AM, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer. 2002;94:3192-3209.
15. Cooke KR, Spears GF, Elder DE, Greene MH. Dysplastic nevi in a population-based survey. Cancer. 1989;63:1240-1244.
16. Hughes-Davies TH. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;339:347-348.
17. Hansen CB, Wadge LM, Lowstuter K, Boucher K, Leachman SA. Clinical germline genetic testing for melanoma. Lancet Oncol. 2004;5:314-319.
18. Mantelli M, Barile M, Ciotti P, et al. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Am J Med Genet. 2002;107:214-221.
19. Puig S, Malvehy J, Badenas C, et al. Role of CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol. 2005;23:3043-3051.
20. Crutcher WA, Sagebiel RW. Prevalence of dysplastic nevi in a community practice. Lancet. 1984;1:729.
21. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.